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ABSTRACT
Access to regulatory elements of the genome can
be inhibited by nucleosome core particles arranged
along the DNA strand. Hence, sites that are access-
ible by transcription factors may be located by using
nuclease digestion to identify the relative nucleo-
some occupancy of a genomic region. In order to
define novel cis regulatory elements in the  2.7-kb
promoter region of the cystic fibrosis transmem-
brane conductance regulator (CFTR) gene, we
define its nucleosome occupancy. This profile re-
veals the precise positions of nucleosome-free
regions (NFRs), both cell-type specific and others
apparently unrelated to CFTR-expression level and
offer the first high-resolution map of the chromatin
structure of the entire CFTR promoter in relevant
cell types. Several of these NFRs are strongly
bound by nuclear factors in a sequence-specific
manner, and directly influence CFTR promoter activ-
ity. Sequences within the NFR1 and NFR4 elements
are highly conserved in many human gene pro-
moters. Moreover, NFR1 contributes to promoter ac-
tivity of another gene, angiopoietin-like 3 (ANGPTL3),
while NFR4 is constitutively nucleosome-free in pro-
moters genome wide. Conserved motifs within NFRs
of the CFTR promoter also show a high level of pro-
tection from DNase I digestion genome-wide, and
likely have important roles in the positioning of nu-
cleosome core particles more generally.
INTRODUCTION
Transcriptional regulation of genes depends in part on
interactions between DNA-binding transcription factors
and their cognate genomic regulatory elements. These
interactions are profoundly inﬂuenced by the chromatin
structure associated with a given regulatory element: tran-
scription factors are less likely to bind to sequences found
in condensed heterochromatic regions than those in more
’open’euchromatic genomic regions.The fundamental unit
of chromatin structure, the nucleosome, is a primary
barrier for transcription factor binding. Thus, heterochro-
matin is characterized by densely packed nucleosomes that
can adopt higher-order ﬁber structures, while euchromatic
nucleosomes are less compacted and hence less of the
double-stranded genomic DNA is nucleosome-bound.
Within euchromatic regions of the genome, the position-
ing of nucleosomes relative to the DNA strand is
determined in an active manner by chromatin remodeling
enzymes (1), and in a passive manner by the DNA
sequence itself and binding competition with transcription
factors (2). The relative contribution of these inﬂuences is
a matter of some debate, yet it remains clear that within
the important regulatory regions of any gene, such as the
promoter and its enhancers, the elements required for
transcriptional control are more likely to be free from
the nucleosome core particle.
Here, we describe the use of measurements of nucleo-
some occupancy within the cystic ﬁbrosis transmembrane
conductance regulator (CFTR) gene promoter to predict
the locations of novel regulatory elements. The promoter
of CFTR, the causal gene for cystic ﬁbrosis, has similari-
ties to housekeeping gene promoters in that it lacks a
TATA-box, is GC-rich and contains several putative
binding sites for the Sp1 GC box-binding transcription
factor (3–5). However, CFTR expression is restricted to
speciﬁc cell types, which include specialized epithelial cells
in the airway, pancreas, small intestine and male genital
ducts (6–10), among others (11–13). Several important
regulatory elements that help determine this tissue-speciﬁc
expression pattern were identiﬁed outside the CFTR
promoter and some were shown to directly interact
with it (14–23). Thus, while the promoter alone does not
coordinate the cell-type speciﬁc transcriptional regulation
of the CFTR gene, it is an important conduit for
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preted and relayed to the general promoter-associated
RNA polymerase II machinery by multiple bound tran-
scription factors. Indeed, regulatory regions were chara-
cterized that include a cyclic AMP response element
(CRE) (24,25), an inverted Y-box (26,27), an NF-kB
binding site (28) and a CArG-like motif (29). These
elements contribute to transcriptional initiation from sev-
eral transcriptional start sites mapped in different CFTR-
expressing cell types (3–5,30). Furthermore, a number of
genetic alterations were detected in the promoter region of
cystic ﬁbrosis patients including single-nucleotide changes
and deletions. These may cause disease or inﬂuence the
disease phenotype either positively (31) or negatively
(32) (see the Cystic Fibrosis Mutation Database at www.
genet.sickkids.on.ca). We found that in addition to these
characterized features of the CFTR promoter, speciﬁc
nucleosome-depleted regions bind nuclear factors and
contribute to promoter activity. Several motifs in these
nucleosome-depleted regions are highly conserved and
found in many promoters throughout the genome. These
studies enable a more intricate understanding of the regu-
latory mechanisms at work in the complex CFTR
promoter region. Moreover, they provide a detailed de-
scription of the chromatin architecture that contributes
to the inactive and active state of the gene, and demon-
strate a robust experimental approach for regulatory
element discovery at speciﬁc genomic regions.
MATERIALS AND METHODS
Micrococcal nuclease assays
Micrococcal nuclease (MNase) was used to generate
mononucleosomal DNA fragments for quantitative poly-
merase chain reaction (qPCR)-based nucleosome occu-
pancy analysis. 1 10
7 cells were resuspended in 10ml
media [Dulbecco’s modiﬁed eagle’s medium with 10%
serum] and crosslinked with 0.37% formaldehyde for
10min on a rocker, and quenched with the addition of
1.5ml 1M glycine. The cells were then pelleted and
washed 2X with cold phosphate-buffered saline (PBS), re-
suspended in 500ml Resuspension buffer (RSB) (10mM
Tris–Cl pH 7.4, 10mM NaCl, 3mM MgCl2), and lysed
with 0.1% NP-40 (dissolved in 14ml RSB). The cells were
inverted 10X in the NP-40/RSB, to aid lysis; the tube was
then spun to pellet nuclei. Nuclei were resuspended in 1ml
RSB and 1500U MNase (Fermentas) was added. The
sample was digested O/N at 37 C with gentle shaking.
Following digestion, 10ml RNase was added and incu-
bated at 37 C for 1h. Then, 10ml proteinase K was
added and incubated at 45 C for 1h. The sample was
then extracted with phenol:chloroform: isoamyl alcohol
(25:24:1 v/v) and ethanol precipitated. The DNA pellet
was washed with 70% ethanol and resuspended in 50ml
H2O. A small sample was then run on a 2% agarose gel to
check for adequate digestion (a predominant  150-bp
band). As a control, undigested genomic DNA was pre-
pared as above with no MNase added. The samples were
diluted to a concentration of 5ng/ml using the Quant-iT
TM
PicoGreen ds-DNA kit (Invitrogen) and a Turner
Biosystems ﬂuorimeter.
Primer sets for qPCR analysis of mononucleosomal
DNA were designed to amplify  60–80-bp regions of
the promoter region with  20-bp overlaps. A standard
curve for each primer set was generated using a serial
dilution of genomic DNA, and the respective ampliﬁca-
tion efﬁciency for each primer set was determined. Primers
used in these assays are listed in Supplementary Table S1.
All PCR products were run on a 10% polyacrylamide gel
and stained with ethidium bromide to conﬁrm a single
major ampliﬁcation product. To determine the relative
nucleosome occupancy associated with each primer set,
the following equation was used:
10^ððCtMNase   CtNoMNaseÞ=ðmÞÞ
where m is the slope taken from the standard curve
generated for each primer set. Nucleosome occupancy
maps were generated by plotting the midpoints of each
amplicon relative to the CFTR translational start site
versus the MNase/No MNase nucleosome occupancy
ratio calculated as above. A best-ﬁt cubic spline curve
was then ﬁtted to the data points using the Prism statis-
tical program (GraphPad Software).
qRT-PCR
CFTR expression was assayed as described previously
using a Taqman primer/probe set spanning CFTR exons
5 and 6 (TAQEX5/6) (33).
Electromobility shift assays
Complementary single-stranded oligonucleotides (Figure 4
and Supplementary Table S1 for sequences) were annealed
and labeled with [a-
32P]-dCTP by ﬁll-in reactions with
Klenow DNA polymerase, prior to puriﬁcation with
microspin G-25 columns (Amersham Biosciences).
Labeled DNA probes were incubated for 15min with
5mg nuclear extract in a ﬁnal reaction volume of 20ml
containing 20% (v/v) glycerol, 20mM HEPES pH 8.0,
4mM MgCl2, 100mM KCl, 32mM NaCl, 0.4mg/ml
bovine serum albumin (BSA), 20mM DTT and 0.05mg/ml
poly(dI–dC). For competition electromobility shift assay
(EMSA), the nuclear extract was preincubated with un-
labeled oligonucleotide duplexes at 10-, 50- and 100-fold
excess molar concentrations for 20min at room tempera-
ture before addition of labeled DNA. The samples were
resolved on a 4% polyacrylamide gel at 4 C for 1.5h at
300V. Following electrophoresis, gels were dried and
exposed to a phosphorimager screen.
Cell culture
The human colon carcinoma cell lines Caco2 (34), SV40
immmortalized 16HBE14o- bronchial epithelial cells (35),
Beas-2B cells (36) and MCF7 cells (37) were grown in
DMEM (Invitrogen) supplemented with 10% fetal bovine
serum (FBS). Primary skin ﬁbroblasts (GM08333) (38)
were grown in MEM (Invitrogen) supplemented with
15% FBS. Primary tracheal epithelial cells were extracted
from post-mortem human adult trachea as previously
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bronchial epithelial (NHBE) cells, a mixture of primary
human bronchial and tracheal epithelial cells (Lonza,
CC-2541) were cultured in BEGM (Lonza) per the manu-
facturer’s instructions.
Promoter:reporter transient transfection assays
Construction of the pGL3.2kb CFTR promoter-
Luciferase reporter plasmid has been described previously
(40). The ANGPTL3 promoter (chr1:63,062,266-
63,063,303; hg19) was ampliﬁed by PCR from human gen-
omic DNA and cloned into the pGL3-Basic vector
(Promega) to create pGL3B-ANGPTL3. Point mutations
in the pGL3.2kb CFTR plasmid and pGL3B-
ANGPTL3mutNFR1 were generated using the
QuikChange Mutagenesis kit or the Lightning Multi
Site-Directed Mutagenesis Kit (Stratagene/Agilent) per
the manufacturer’s instructions using primers listed in
Supplementary Table S1. For pGL3.2kb CFTR transient
transfection assays, 16HBE14o- cells were seeded onto
24-well plates and transfected with Lipofectin
(Invitrogen) 24h post-seeding. A pCMV-b-galactosidase
plasmid was co-transfected to control for transfection efﬁ-
ciency. Cells were lysed 36h post-transfection and assayed
for Luciferase and b-galactosidase activity with appro-
priate substrate reagents (Promega). For pGL3B-
ANGPTL3/pGL3B-ANGPTL3mutNFR1 constructs,
Caco-2 cells were transfected with Lipofectamine 2000
(Invitrogen) 48h after plating. Luciferase and
b-galactosidase assays were performed 48h post-
transfection. Data were analyzed for statistical signiﬁ-
cance using an unpaired t-test with Welch’s correction.
Genomic motif analysis
To examine the predicted nucleosome occupancy and
DNase hypersensitivity of genomic motifs in promoter
regions, the refFlat.txt ﬁle, which denotes the genomic
indices of all human RefSeq genes, was downloaded
from the UCSC genome browser (http://hgdownload.cse
.ucsc.edu/goldenPath/hg18/database/). A program was
written to read this ﬁle and generate a list of indices of
the 2-kb upstream region of all protein-coding genes.
Next, a FASTA ﬁle of the genomic DNA corresponding
to these promoter indices was generated and the genom-
ic motifs of interest were identiﬁed among these sequences.
Each occurrence was recorded along with its genomic
position. These genomic sequences and ﬂanking gen-
omic regions were then analyzed with NuPoP (http://
nucleosome.stats.northwestern.edu), a software tool for
nucleosome position prediction (41). The NuPoP score
at each nucleotide position was then averaged over all se-
quences. These genomic indices were also used to extract
the DNase hypersensitivity values (speciﬁcally the DNase-
Seq Base Overlap Signal) of the genomic DNA within
and surrounding each motif, from the ENCODE
Open Chromatin Map generated by Dr G Crawford, Duke
University (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/
encodeDCC/wgEncodeChromatinMap/). These values were
then averaged and plotted to generate a graph of the
average DNase-Seq Base Overlap Signal surrounding the
motifs. The same analysis was performed with conserva-
tion data to illustrate the average DNA conservation
surrounding the motifs. The conservation values
generated by PhastCons were downloaded from the
UCSC genome browser (http://hgdownload.cse.ucsc.edu/
goldenPath/hg18/phastCons28way/vertebrate/).
RESULTS
Nucleosome occupancy of the human CFTR promoter
region
An MNase assay was used to determine the positioning
and relative occupancy by nucleosomes in a region in-
cluding  2200bp upstream of the start of the CFTR trans-
lational start site to 500bp into the ﬁrst intron. A
schematic of the assay design is shown in Figure 1A.
MNase preferentially cleaves non-nucleosomal linker
DNA, and was used to generate mononucleosomal DNA
fragments ( 150bp), which were then used as a template
for qPCR with 54 overlapping PCR primer sets that were
designed across the region. Each primer set ampliﬁed a
 60–80bp product with an average of  20bp overlaps
to achieve mononucleosome resolution (Figure 1B).
Crosslinked chromatin from six different cell types was
digested with MNase: primary human tracheal epithelial
(HTE) cells and primary human bronchial epithelial and
tracheal cells (NHBE) both of which express very low
levels of CFTR, the CFTR-expressing human cell lines
Caco2 (colon carcinoma) and 16HBE14o- (immortalized
bronchial epithelial), and the CFTR low-expressing bron-
chial epithelial cell line Beas2B. Also assayed were
human skin ﬁbroblast cells, which do not express CFTR
(21). As a normalizing control, equal amounts of undigest-
ed genomic DNA were also assayed in the qPCR reactions.
The relative nucleosome occupancy across the region in skin
ﬁbroblasts, expressed as the ratio of MNase-digested to
undigested controls, is shown as an example in Figure 1C
and for each cell type in Figure 2A. Biological repli-
cates for the primary airway samples are also shown in
Figure 2A, and for each other cell type along with data for
the breast adenocarcinoma cell line MCF7, another known
CFTR-negative cell type, in Supplementary Figure S1.
Active promoters generally possess well-positioned nu-
cleosomes at either side of the core promoter region,
deﬁned as the region containing the transcriptional start
site(s) of the gene and consensus general transcription
factor binding elements such as the TATA-box, initiator
(Inr), and others (42). The MNase assay detected pos-
itioned (or phased) nucleosomes throughout the
interrogated region, with the most well-positioned nucleo-
somes ﬂanking the region containing the transcriptional
start sites and most well-characterized trans-factor binding
sites in each cell type, regardless of expression level
(Figures 1C and 2A), (quantitated expression levels for
each cell type shown in Figure 2B). A nucleosome-
depleted region that identiﬁes the core promoter lies
 100–220bp upstream of the translational start site in
16HBE14o- cells, yet appears to be narrower in Caco2
cells (Figure 2A, vertical arrows), perhaps a cause or con-
sequence of cell-type speciﬁc differences in the use of core
Nucleic AcidsResearch, 2012, Vol.40,No. 2 627promoter elements between these cells. In both cell types
that do not express signiﬁcant levels of CFTR transcript
(skin ﬁbroblasts and Beas2B cells), this core promoter
region has higher relative nucleosome occupancy.
Moreover, in the primary tracheal (HTE) and bronchial
(NHBE) cells, which show levels of CFTR expression that
ﬂuctuate in culture but are low in comparison to
16HBE14o- and Caco2 cells, there is some variability in
the nucleosome within the core promoter. Nucleosomes
are clearly depleted over the core promoter in the high ex-
pressing cells, most notably 16HBE14o- but also Caco2
cells, relative to the CFTR-negative cell types. However,
A
B
C
Figure 1. A high-resolution nucleosome occupancy assay of the human CFTR promoter region. (A) A schematic of the MNase assay procedure:
harvested cells are crosslinked with formaldehyde, lysed for isolation of nuclei, and digested with MNase. An undigested genomic DNA sample is
also prepared as a reference control. Both the digested and undigested samples are used as templates in qPCR reactions with overlapping primer sets
tiled across the greater promoter region (B). The scale shown is relative to the ﬁrst base of the ﬁrst coding CFTR exon. The assayed region includes
 2.2kb 50 and 500bp 30 of the translation start site. The 54 primer sets used in the assays are numbered 50–30.( C) The nucleosome occupancy proﬁle
for skin ﬁbroblast cells; numbers along the proﬁle indicate the midpoint of each assayed amplicon. Locations of known promoter regulatory elements
and their cognate trans factors are shown.
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Figure 2. Nucleosome occupancy proﬁles. (A) Data collected from six cell types: high-expressing Caco2 and 16HBE14o- cells, low-expressing Beas2B
and primary airway epithelial cells [primary tracheal (HTE) epithelial and normal human bronchial epithelial (NHBE)], and CFTR-negative skin
ﬁbroblasts. The y-axis represents the ratio of MNase-digested ampliﬁed product to undigested product, while the x-axis represents the coordinates of
the qPCR amplicons. Each experimental value is plotted at the midpoint of the amplicon, and lines are generated using a best-ﬁt cubic spline curve.
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(continued)there is comparatively little difference between the core
promoter nucleosome occupancy of the CFTR-negative
skin ﬁbroblasts, the low expressing Beas2B and primary
airway cells, despite a  10–100-fold difference in tran-
script levels. This could mean that either little or no nu-
cleosome displacement over the core promoter is required
for low levels of transcription, or the nuclease assay is not
sensitive enough to detect small changes in nucleosome
occupancy that correlate with minor alterations in tran-
scriptional activity in these particular cell types.
Interestingly, in all cell types three well-positioned nucleo-
somes are seen between   220 and 700bp upstream of the
translational start site (Figure 2A, stars). Nucleosomes
also occupy consistent positions further upstream,
including two nucleosomes that ﬂank a poly A:T tract, a
sequence known to displace nucleosomes (43) at
  1300bp.
Nucleosome-free regions of the CFTR promoter contain
highly conserved elements
Because the DNA wrapped around the nucleosome core
particle can often occlude regulatory motifs from their cog-
nate binding partners, we reasoned that nucleosome-
free regions (NFRs) of the CFTR promoter would contain
potential cis regulatory elements. Moreover, we sought
any sites that might be devoid of nucleosomes in a cell-
type-speciﬁc manner. Observing the nucleosome occu-
pancy proﬁle of CFTR-expressing bronchial epithelial
16HBE14o- cells revealed the region from  200 to
250bp upstream of the ﬁrst exon that is speciﬁcally
nucleosome-depleted when compared to the other cell types,
including the CFTR-expressing Caco2 cells (Figures 2A
and 3A). This region is predicted to be concealed by a
well-positioned nucleosome based on its sequence charac-
teristics as determined by the nucleosome occupancy
model developed by Kaplan et al. (44) (Figure 3B). The
other NFRs that ﬂank or lie between the three well-phased
nucleosomes that lie immediately 50 of the core promoter
[and that are relatively consistently positioned between all
the cell types assayed (Figure 2, stars)] align very closely
with the sequence-based prediction algorithm.
When the nucleosome occupancy data are aligned with
a sequence conservation track (PhastCons) of 28 mamma-
lian species developed for the ENCODE Consortium (45),
strikingly many of the most conserved regions fall within
NFRs (Figure 3C). Of the four NFRs that ﬂank or lie be-
tween the three phased nucleosomes from  220 to  700bp
(referred to as NFR1-4, highlighted in Figure 3C), three
(NFR1, NFR2 and NFR4) contain elements that corres-
pond to high sequence conservation. We deﬁne NFR1 as
the most 50 region of the large nucleosome-depleted tran-
scriptional start region observed in 16HBE14o- cells. It is
interesting that this region is nucleosome-protected in the
other cell types, yet contains a speciﬁc region of high con-
servation, which may suggest the presence of a unique
regulatory element uniquely accessible in the 16HBE14o-
cell type. As these NFRs ﬂank some of the most well-
phased nucleosomes of the CFTR promoter region, and
lie relatively close to the promoter core, we focused on
these regions, especially the conserved elements within
them, to determine if they may contribute to CFTR tran-
scriptional regulation.
NFR1 and NFR4 bind protein complexes in vitro
To determine the protein-binding capability of NFRs 1–4,
we designed double-stranded oligonucleotides that
spanned the highly conserved regions of each (no highly
conserved element exists within NFR3, so a probe was
designed to span the estimated center of the NFR).
These probes were used in EMSAs together with nuclear
extracts from CFTR-expressing 16HBE14o- and Caco2
cells (Figure 4A). With both nuclear extracts, the con-
served regions of NFR1 and NFR4 strongly bound
protein complexes, while NFR2 and NFR3 showed faint
shifts. The NFR4 probe generated a single major complex
(Figure 4A, left arrow) which was more abundant with the
16HBE14o- nuclear extract, while additional minor
complexes were also present. The NFR1 probe generated
two distinct and abundant complexes (Figure 4A, right
arrows) with both nuclear extracts, with additional minor
complexes. These protein complexes however are not
unique to cells expressing high levels of CFTR, as nuclear
extract puriﬁed from Beas2B cells formed the same
complexes (Supplementary Figure S2). To establish that
these protein complexes were generated by sequence-
speciﬁc binding to the probes, EMSAs were performed
with both the NFR1 and NFR4 probes using
16HBE14o- nuclear extract and competition with increas-
ing amounts of unlabelled probe (10-, 50- and 100-fold
molar excess) (Figure 4B). Complex formation with both
NFR1 and NFR4 labeled probes was efﬁciently disrupted
by excess cold probe but not by mutant probes in which
either three (NFR4) or four (NFR1) bases within the
highly conserved element were mutated.
In an effort to determine the identity of the factors that
bind to these elements, the critical core sequences were
analyzed by the MatInspector transcription factor binding
prediction program (Genomatix, www.genomatix.de),
which did not predict binding by any known factors.
Although NFR4 contains a GATA base sequence, this is
not in the (A/T)GATA(A/G) context of the consensus for
GATA transcription factor binding. However, some
GATA factors are known to bind alternative consensus
sites (46) and thus NFR4 may represent a constitutively
accessible site for some GATA factors.
Figure 2. Continued
The skin ﬁbroblast trace (gray dotted line) is reproduced on each graph for comparison to a CFTR-negative cell type. Each qPCR reaction was
performed in duplicate; error bars are omitted for clarity, and data for a second biological replicate for 16HBE14o-, Caco2, Beas2B and skin
ﬁbroblast cells is included in Supplementary Figure S1. Arrows on Caco2 and 16HBE14o- tracks signify the estimated core promoter region.
Asterisks on each track show positions of 3 positioned nucleosomes 50 to the core promoter region. (B) CFTR mRNA levels for each cell type
measured by qRT–PCR. Each value is shown as fold difference from skin ﬁbroblast RNA; error bars represent SEM, n=3.
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CFTR transcriptional regulation
To determine if these motifs and the factors they recruit
in vitro have any direct inﬂuence on CFTR promoter
activity, we performed transient transfections in
16HBE14o- cells using reporter vectors with  2kb of
the wild-type CFTR promoter cloned 50 of the luciferase
gene. We previously showed that this 2kb sequence, which
encompasses the minimal ’core’ promoter region and
other known regulatory elements upstream, maximally ac-
tivates gene expression in these assays in 16HBE14o- cells
(40). The same base pairs were mutated in both NFR1 and
NFR4 as in the EMSA competition experiments (Figure
4). Mutating 4bp in NFR1 resulted in a signiﬁcant
decrease (90%, P<0.0001) in promoter activity relative
to the wild-type sequence, which suggests that the factor
that binds to this motif is an activating transcription
factor. Conversely, a 3bp change in the NFR4 motif mar-
ginally increased promoter activity (26%, P=0.018), sug-
gesting that the factor that binds to this site plays a
different role at the CFTR promoter.
Several mutations in the CFTR promoter, which occur
at trans factor binding sites of regulatory elements, were
previously identiﬁed in CF patients (6,32). Hence, the
A
B
C
Figure 3. Nucleosome free (or depleted) regions of the CFTR promoter contain potential regulatory elements. (A) The nucleosome occupancy proﬁle
of the CFTR-expressing bronchial epithelial cell line 16HBE14o-. Highlighted are the nucleosome-free regions (NFRs 1–4) that fall between or ﬂank
the  3 relatively well-positioned nucleosomes that lie immediately 50 of the ’core’ CFTR promoter that contains the major transcriptional start sites.
The x-axis is numbered as in Figure 1. (B) The predicted nucleosome occupancy (based solely on DNA sequence) of the CFTR promoter region
derived by using the in silico model proposed in ref. 44 (C) The assayed region of the CFTR promoter aligned with the PhastCons mammalian
species conservation track from the ENCODE Consortium (http://genome.ucsc.edu/ENCODE). Higher peaks represent increased sequence conser-
vation among 28 mammalian genome alignments.
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regulatory element mutations was of interest. To
evaluate these relative effects of NFR1/NFR4 mutations
on CFTR promoter activity we generated reporter vectors
that contained promoter mutations/polymorphisms that
were identiﬁed in CF patients. Three of these variants
were previously tested in a much smaller basal CFTR
promoter fragment (362bp, compared to 2kb used in
the current studies) driving luciferase expression in
reporter vectors. The  33G>A mutation alters a pre-
dicted FoxI1 site and reduced CFTR promoter activity
by about 50% in immortalized male genital duct epithelial
cells (6,47). The  94G>T mutation disrupts Sp1/USF
binding and decreased CFTR promoter activity by about
30% in a cell-type-speciﬁc manner (32). The  102T>A
polymorphism, which correlates with milder forms of
disease (31,48), introduces a binding site for the transcrip-
tion factor YY1, increasing CFTR promoter activity by
about 45–66% depending on the cell type used for transi-
ent transfections. The  329C>T mutation/ polymorphism
(CF Mutation database, unpublished, submitted
by Wallace and Tassabehji, St. Mary’s Hospital,
Manchester, England), which has not been evaluated pre-
viously, was also introduced into the 2kb CFTR promoter
fragment driving luciferase expression. All constructs
were transfected into 16HBE14o- cells (Figure 5A) and
demonstrate that though the effects of each mutation
was smaller than reported in the 362-bp basal promoter
in different cell types, the trends were similar. Speciﬁcally,
 33G>A and  94C>T reduced promoter activity
(21%, P=0.0057 and 13%, respectively, P=0.075ns)
as did  329C>T (18%, P=0.0134). The  102A>T
change augmented promoter strength (26%, P=0.0127)
similarly to the mutation of NFR4 (26%, P=0.018). Of
note, the  94C>T and  102T>A changes are located just
30 of the NFR1 site within the CFTR core promoter region
that is depleted of nucleosomes in 16HBE14o- cells. Most
importantly the effect on promoter activity of mutating
NFR1 is signiﬁcantly greater (90%, P<0.0001) than
that seen in any of the disease-associated mutations, sup-
porting its critical role in CFTR expression.
We next investigated whether the NFR1 motif has a
similar role in transcriptional activation where it occurs
in promoters at other locations in the genome (see below).
We cloned the promoter of the angiopoietin-like 3 gene
(ANGPTL3), which contains a single NFR1 motif (GTG
GAGAAAG) 494bp upstream of its ﬁrst exon. Mutation
of three bases in the NFR1 motif of the ANGPTL3
promoter resulted in a signiﬁcant decrease in promoter
activity (Figure 5B) (27%, P<0.0001) when transiently
transfected into Caco2 cells. Although the effect is
slightly less than the CFTR NFR1 mutant in
16HBE14o- cells, these data demonstrate that this motif
likely acts as a positive cis regulatory element at multiple
promoter locations in the genome.
The NFR4 conserved motif is typically within nucleosome-
depleted and DNase-protected regions of promoters
We then sought to determine whether these regulatory
motifs of the CFTR promoter, which we ﬁrst deﬁned as
AB
Figure 4. In vitro binding of protein complexes to CFTR promoter NFRs. (A) EMSA with probes spanning regions of NFRs 1–4 using nuclear
extract from the CFTR-expressing cell types Caco2 and 16HBE14o-. Major complexes are observed with probes for NFR4 (single arrow) and NFR1
(two arrows), while NFRs 2 and 3 show very slight protein complex formation. (B) Speciﬁcity of complex formation with 16HBE14o- nuclear
extracts shown by EMSAs with unlabeled NFR4 and NFR1 oligonucleotides. These efﬁciently compete complex formation at 10-, 50- and 100-fold
molar excess, while mutant oligos (mutated bases shown in gray) are inefﬁcient competitors up to 100-fold molar excess.
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conservation proﬁle, may have the same characteristics
genome wide. We searched every promoter in the
genome (including up to 2kb upstream of ﬁrst exons)
for both the NFR1 and NFR4 motifs (NFR1: GTGGA
GAAAG; NFR4: TTTTGATA). The NFR1 motif occurs
in 138 promoters while the shorter NFR4 motif occurs in
936 promoters. NFR1 is found twice in a single gene
promoter (TSSC4), while NFR4 is found twice in 35 pro-
moters and three times in two promoters (OR2G3
and SETDB2). To understand the chromatin-associated
characteristics of all of these motifs, we used genome-wide-
nucleosome occupancy prediction analysis (NuPoP) (http://
nucleosome.stats.northwestern.edu) (41) and DNase-
hypersensitivity data available from the ENCODE
Consortium (http://genome.ucsc.edu/ENCODE) (49). We
compiled the surrounding sequences for each promoter
motif (5kb or 1kb both 50 and 30 from the motif) and
generated the average nucleosome occupancy prediction
score, which is based solely on sequence characteristics
of all promoter NFR1 and NFR4 sites across the
genome. This analysis shows that the NFR4 motif is spe-
ciﬁcally disfavorable to nucleosome occupancy, while the
NFR1 motif is neutral (Figure 6A). This corresponds to
the nucleosome occupancy scores found for the CFTR
promoter region itself (Figure 3B). Figure 6B shows
genome-wide analysis of the same sequences and high-
resolution DNase-hypersensitivity by overlapping 10bp
sequencing tags (5bp on each end of a mapped DNase-
digestion site). We generated the average base overlap
values for each base surrounding the motif using datasets
for HelaS3 (Figure 6B) and HepG2 (Supplementary
Figure S3) cell lines. The average DNase-hypersensitivity
proﬁle of the NFR4 motif shows that throughout the
promoter-associated genome, it occupies a speciﬁc local-
ized region protected from DNase-cleavage, whereas the
NFR1 motif is much less deﬁned (Figure 6B).
Interestingly, when the same analysis is performed on
the 3-bp mutant version of the motif used in the reporter
assays (427 occurrences in promoters) there is no longer a
localized region of DNase protection (Figure 6C). This
suggests that at promoters genome-wide, this motif is con-
sistently bound by a trans factor that inhibits DNase di-
gestion in a sequence-speciﬁc manner.
Using the sequence conservation track generated by the
ENCODE Consortium in which genome alignments from
28 mammalian species are compiled with the PhastCons
algorithm peak tracks of sequence conservation, we
generated the average conservation of promoter sequences
ﬂanking 2kb 50 and 30 of the NFR4 motif genome wide.
The NFR4 motif occupies a speciﬁc region of localized
conservation, further signifying that this motif has import-
ant chromatin-associated regulatory properties in
promoter regions (Figure 6D).
DISCUSSION
Understanding and deciphering the precise regulatory
characteristics of the human genome is a signiﬁcant chal-
lenge. Beyond the DNA sequence of genes, a signiﬁcant
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Figure 5. (A) Mutation of NFR1 inhibits CFTR promoter activity more profoundly than several CF disease-associated mutations. 16HBE14o- cells
were transfected with pGL3B luciferase reporter constructs containing the 2-kb CFTR greater promoter region (pGL3:2kbProm) and a
b-galactosidase transfection control plasmid. Promoter mutants: 33G>A,  94G>T,  102T>A, NFR1mut,  329C>T and NFR4mut are shown
relative to the CFTR basal promoter-alone vector. (B) Mutation of NFR1 in the ANGPTL3 promoter decreases promoter activity in Caco2 cells.
Error bars represent standard errors of the mean [n=6 or 9 (CFTR and ANGPTL3)]. P-values generated by comparison to the wild-type
promoter-only vector by using unpaired t-tests with Welch’s correction. Experiments were done a minimum of three times and with more than
one plasmid preparation of each construct and results were consistent between them.
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Figure 6. Genome-wide promoter proﬁle of NFR1 and NFR4. (A) The nucleosome occupancy prediction scores of all human promoters that
contain either NFR1 or NFR4 motifs. Y-axis represents the NuPoP nucleosome occupancy score (see ‘Materials and Methods’ section for explan-
ation). The x-axis represents the distance (in base pairs) from the start of the ﬁrst base of the motif. The data points representing the motifs are
shown in black, all other data points in gray. (B) The DNase I-hypersensitivity proﬁles of all human promoters that contain either NFR1 or NFR4
motifs. Y-axis represents the Base Overlap signal given by raw sequence data from DNase-seq experiments performed with HelaS3 cells. (C) The
DNase I-hypersensitivity proﬁle of all human promoters that contain the NFR4mut (mutant) motif. (D) The PhastCons score for the NFR4 motif
across all human promoters.
634 Nucleic Acids Research, 2012,Vol. 40,No. 2amount of genomic regulatory capability is realized at the
chromatin level, which can include both the post-
translational modiﬁcation of histones and positioning of
nucleosomes. Thus, mapping precise nucleosome positions
and their relative occupancy on the DNA strand can be a
robust strategy for regulatory element discovery. While
nuclease digestion of chromatin has long been used as a
method for uncovering in vivo characteristics of genomic
regions, the advent of precise quantitative PCR methods
and more recently high-throughput sequencing of the
whole genome have enabled increasingly precise analysis
of genome structure. MNase was used to map nucleosome
occupancy of the entire yeast (44), worm (50) and human
genomes (51) with next-generation sequencing. However,
the large size of the human genome currently prohibits
sequence-based data generation at the high-resolution
obtained here for the CFTR promoter using a qPCR
method. Nevertheless, cumulatively these studies show
that nucleosomes are often positioned away from speciﬁc
sites for DNA-binding factors, and that nucleosomes
have speciﬁc occupancy and positioning characteristics
at promoter regions. Chromatin immunoprecipitation
(ChIP)-sequencing has similarly been used to uncover
nucleosome-depleted regions over human enhancers asso-
ciated with histone H3 dimethylated lysine 4 marks (52),
which also reveals speciﬁc depletion of nucleosomes over
transcription factor binding sites.
Previous work uncovered a number of important tran-
scriptional regulatory elements within the CFTR promoter
(3–5,25,26,28,29) and enhancers elsewhere in the locus (23)
some of which interact directly with the promoter region
in vivo via a looping mechanism (21,22). The molecular
machinery underlying these enhancer–promoter inter-
actions must rely on the direct DNA-binding of speciﬁc
trans factors to both cis-acting elements and the promoter.
However, the identiﬁcation of many of the trans-acting
factors required for CFTR transcription has been
challenging, particularly in airway epithelial cells. The
cell types used in this study included epithelial cells of
both airway and intestinal origin, to model tissue-speciﬁc
expression of CFTR, and also skin ﬁbroblasts, which lack
CFTR. Several promoter NFRs were identiﬁed which
were either constitutive or cell-type speciﬁc, yet despite a
wide range of CFTR-expression levels, the nucleosome oc-
cupancy proﬁle in each cell type was remarkably similar.
This may signify that the CFTR promoter regulation is
governed primarily by the relative presence of trans
factors, or that the composition of histones at the
promoter (i.e. modiﬁed histones and/or histone variants)
plays a predominant role. While the MNase assay does
not offer a direct quantitative correlation between core
promoter nucleosome occupancy and mature transcript
level, several qualitative characteristics can be discerned
from the proﬁles. Some cell-type-speciﬁc NFRs do seem
to signify elements of cell-type-speciﬁc promoter regula-
tion. NFR1 is speciﬁcally nucleosome-depleted in
16HBE14o- cells when compared to the high-expressing
intestinal Caco2 cell line and the other low-expressing
primary cell types. As nuclear factors from both Caco2
and 16HBE14o- associate with this element in vitro, this
may signify that an important aspect to CFTR
transcription in 16HBE14o- cells could involve the activity
of speciﬁc nucleosome remodelers that either evict or re-
locate a nucleosome away from this element to allow
factor binding. Indeed, the NFR1 motif is not predicted
to be nucleosome-depleted at either the CFTR promoter
alone or throughout promoters of the genome, suggesting
that trans factor access to this regulatory element requires
the alteration of local chromatin structure. The larger
nucleosome-depleted region of the core promoter in
16HBE14o- cells when compared to Caco2 cells, which
express a similar level of CFTR transcript, may also
indicate a tissue-speciﬁc characteristic that contributes to
transcriptional regulation. NFR4, however, seems to rep-
resent a ‘barrier sequence’ as has recently been described
by others in yeast (53) and human primary cells (54),
which is probably due to the TT dyads found in the
motif. This motif is disfavorable to nucleosome occu-
pancy, both at the CFTR promoter and in other pro-
moters elsewhere in the genome, where it likely
contributes to the positioning of nucleosomes that ﬂank
the motif. We provide evidence here that this ‘barrier’
nucleosome-positioning sequence is bound by a
sequence-speciﬁc trans factor, which may be responsible
for its chromatin-organizing characteristics. In support of
this, we show that this motif is speciﬁcally resistant to
DNase I-cleavage genome wide, which indicates the
presence of a unique bound factor at these sites. These
localized DNase I-resistant sites have been reported with
other motifs, although the identity of the trans factors
responsible have not been identiﬁed (55). It seems probable
that the nuclear proteins interacting with NFR1 and
NFR4 may not be well-characterized transcription
factors, since in silico transcription factor binding site pre-
diction programs (Matinspector) failed to identify candi-
date interacting factors. Initial attempts to identify the
nuclear factors that associate with NFR1 and NFR4 by
DNA-afﬁnity chromatography using biotinylated oligo-
nucleotides did not isolate speciﬁc trans factors and will
likely require signiﬁcant advances in transcription factor
isolation techniques for success. Alternatively, it may be
possible to use indirect methods to capture the proteins
interacting with the NFRs, by exploiting recent advances
in understanding the three-dimensional structure of the
active CFTR locus (21,22), The intronic enhancers that
determine cell-type-speciﬁc expression of the gene are
known to interact directly with the promoter via a
looping mechanism. Moreover, some of the transcription
factors that generate functional complexes at these enhan-
cers are already known (20). Thus, a combination of
ChIP-based techniques, among others, using these
known factors as ‘bait’, may elucidate the trans-acting
factors and co-factors that interact with the NFR
elements at the promoter. These advances will provide
further insights into general promoter architecture and
how nucleosome positioning is maintained during tran-
scriptional activation of CFTR. The fact that the NFR1
and NFR4 elements are found in multiple human gene
promoters and that mutation of NFR1 in the
ANGPTL3 promoter compromised its activity suggest
these insights will be applicable to promoter function
more generally.
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